NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球腸病檢測市場(~2026 年):技術(常規檢測/快速檢測)/應用(食品(肉類、雞肉、海鮮、乳製品、加工食品、水果和蔬菜)、水)、病原體、其他地區

Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region - Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1026966
出版日期 內容資訊 英文 274 Pages
訂單完成後即時交付
價格
全球腸病檢測市場(~2026 年):技術(常規檢測/快速檢測)/應用(食品(肉類、雞肉、海鮮、乳製品、加工食品、水果和蔬菜)、水)、病原體、其他地區 Enteric Disease Testing Market by Technology (Traditional and Rapid), End Use (Food (Meat, Poultry, Seafood, Dairy, Processed Foods, and Fruits & Vegetables) and Water), Pathogen Tested, and Region - Global Forecast to 2026
出版日期: 2021年08月26日內容資訊: 英文 274 Pages
簡介

在預測期內,全球腸病檢測市場預計將以 6.0% 的複合年增長率增長,從 2021 年的 18 億美元增長到 2026 年的 24 億美元。我是。

對污染物檢測實施嚴格規定、消費者意識增強以及因潮濕環境導致食物中毒增加等因素正在推動該市場的增長。

就最終用戶行業而言,食品行業的份額最大。國際貿易的擴大產生了對全球食品安全義務和法規的需求,這是市場增長的重要驅動力。在技□□術方面,預計快速技術部門將擁有最大的市場份額。

本報告探索全球腸病檢測市場,定義和概述市場,分析新型冠狀病毒感染(COVID-19)和其他市場影響因素、監管環境、技術和專利。分析、案例研究、市場規模趨勢/預測,按各種類別分類,例如病原體/最終用途/技術/地區/主要國家,競爭環境,主要公司簡介等。

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

  • 宏觀經濟指標
  • 市場動態
    • 促進因素
    • 抑製器
    • 市場機會
    • 挑戰

第六章產業趨勢

  • 監管框架
  • 波特五力分析
  • 市場生態系統
  • 供應鏈分析
  • 技術分析
  • 專利分析
  • 案例研究
  • 困惑影響市場買家
  • COVID-19 的影響

第 7 章市場分析/預測:按病原體

  • 大腸桿菌
  • 沙門氏菌
  • 彎曲桿菌
  • 李斯特菌
  • 其他

第 8 章市場分析/預測:按最終用途

  • 食物
    • 肉類、雞肉、海鮮
    • 乳製品
    • 加工食品
    • 水果和蔬菜
    • 其他

第 9 章市場分析/預測:按技術

  • 常規檢查
  • 快速檢查
    • 便利基地
    • PCR
    • 免疫測定
    • 色譜/光譜分析

第 10 章市場分析/預測:按地區/主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 其他領域

第11章競爭形勢

  • 大公司的戰略
  • 市場份額分析
  • COVID-19:特定公司的通信
  • 企業評估象限:主要公司
  • 產品足跡
  • 企業評估象限:初創公司/中小企業
  • 衝突場景

第12章公司簡介

  • 主要公司
    • SGS SA
    • MERCK KGAA
    • THERMO FISHER SCIENTIFIC INC.
    • EUROFINS SCIENTIFIC
    • ALS LIMITED
    • ASURE QUALITY
    • BUREAU VERITAS
    • INTERTEK
    • BIO-RAD LABORATORIES, INC.
    • BECTON DICKINSON
    • 3M
    • PERKINELMER, INC.
    • NEOGEN CORPORATION
    • MERIEUX NUTRISCIENCES
    • TUV SUD
  • 其他有力企業
    • HARDY DIAGNOSTICS
    • ROMER LABS
    • NOVA BIOLOGICALS
    • SYMBIO LABORATORIES
    • CERTIFIED LABORATORIES

第13章 相關市場

第14章 附錄

目錄
Product Code: FB 7970

The global market for enteric disease testing is estimated at USD 1.8 billion in 2021; it is projected to grow at a CAGR of 6.0% to reach USD 2.4 billion by 2026. Foodborne illnesses have affected socioeconomic development by straining health care systems and trade. The factors fueling the growth of the enteric disease testing market are the implementation of stringent regulations related to contaminant detection, growth in consumer awareness, and humid atmospheric conditions, which are leading to an increase in contamination in food. In order to address enteric disease concerns, caused by foodborne illness, skey players in the various regions will need to further improve upon their food safety monitoring programs.

The food segment is estimated to hold the largest market share in the by end use segment for the enteric disease testing market.

The global food trade has been expanding and providing consumers with access to a wider variety of foods throughout the year. Expanding trade has led to the emergence of food contaminants, bringing diversity of food safety regulations and standards in different countries into focus. Growth in international trade creates the need for global mandates and regulations on food safety, which is a significant factor that drives the market for enteric disease testing.

By technology, the rapid technology segment is projected to account for the fastest market share in enteric disease testing market.

Rapid technology is widely used by various testing companies as it offers various advantages like quick results, greater sensitivity, and reliability, which have enabled manufacturers of assured claims to provide safety and quality in their products. Technological advancements, such as chromatography and spectrometry, witness low adoption in South America and Africa but witness increasing adoption in countries of the Asia Pacific region due to the growing investments from current market leaders.

The meat, poultry and seafood sub-segment within the food end use segment is estimated to hold the largest market share of enteric disease testing market over the forecast period.

Bacterial contamination takes place at all stages of slaughtering, leading to foodborne diseases. Defeathering or skinning is a stage where maximum contamination occurs due to improper handling of animals and unhygienic conditions. Inappropriate equipment cleaning procedures have been responsible for the cross-contamination of products. Thus, the demand for their testing is increasing in meat, poultry, and seafood products

The North American region is estimated to account for the largest market share in the global enteric disease testing market.

The North American region is considered to have one of the most advanced food safety programs, however, it faces major challenges. Several factors affect food safety, these include introduction & use of new technologies, more sophisticated distribution systems, inappropriate production and manufacturing systems, and increased access to imported foods. Outsourcing enteric diseases testing has benefited food producers in cutting down costs and has encouraged the growth of this market.

Break-up of Primaries

  • By Company Type: Tier 1: 65%, Tier 2: 20%, and Tier 3: 15%
  • By Designation: C-Level - 45%, Director Level - 30%, others- 25%
  • By Region: North America - 10%, Europe - 45%, Asia Pacific - 25%, South America - 5%, and Rest of the World (RoW) - 15%.

Leading players profiled in this report

  • SGS SA (Switzerland)
  • Eurofins Scientific (Luxembourg)
  • Intertek Group plc (UK)
  • Bureau Veritas (France)
  • ALS Limited (Australia)
  • TUV SUD (Germany)
  • NEOGEN Corporation (US)
  • Merieux NutriSciences (US)
  • AsureQuality (New Zealand)

Research Coverage

This report segments the enteric disease testing market on the basis of pathogen tested, technology, end use, and region. In terms of insights, this research report focuses on various levels of analyses-competitive landscape, end-use analysis, and company profiles-which together comprise and discuss the basic views on the emerging & high-growth segments of the Enteric disease testing market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.

Reasons to buy this report

  • To get a comprehensive overview of the enteric disease testing market
  • To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them.
  • To gain insights about the major countries/regions, in which the enteric disease testing market is flourishing.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • FIGURE 1 ENTERIC DISEASE TESTING MARKET SEGMENTATION
    • 1.3.1 REGIONAL SEGMENTATION
  • 1.4 INCLUSIONS & EXCLUSIONS
    • 1.4.1 PERIODIZATION CONSIDERED
  • 1.5 CURRENCY CONSIDERED
    • TABLE 1 USD EXCHANGE RATES, 2015-2019
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 ENTERIC DISEASE TESTING MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key industry insights
      • 2.1.2.2 Breakdown of primary interviews
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
    • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION METHODOLOGY
    • 2.3.1 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: SUPPLY SIDE
    • FIGURE 6 MARKET SIZE ESTIMATION OF ENTERIC DISEASE TESTING MARKET, 2020
    • 2.3.2 ENTERIC DISEASE TESTING MARKET SIZE ESTIMATION: DEMAND SIDE
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
  • 2.6 MARKET SCENARIOS CONSIDERED FOR THE IMPACT OF COVID-19
  • 2.7 SCENARIO-BASED MODELLING
  • 2.8 COVID-19 HEALTH ASSESSMENT
    • FIGURE 7 COVID-19: GLOBAL PROPAGATION
    • FIGURE 8 COVID-19 PROPAGATION: SELECT COUNTRIES
  • 2.9 COVID-19 ECONOMIC ASSESSMENT
    • FIGURE 9 REVISED GROSS DOMESTIC PRODUCT FORECASTS FOR SELECT G20 COUNTRIES IN 2020
    • 2.9.1 COVID-19 ECONOMIC IMPACT-SCENARIO ASSESSMENT
    • FIGURE 10 CRITERIA IMPACTING GLOBAL ECONOMY
    • FIGURE 11 SCENARIOS IN TERMS OF RECOVERY OF GLOBAL ECONOMY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 OPPORTUNITIES IN THE ENTERIC DISEASE TESTING MARKET
  • 4.2 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET, BY END USE & COUNTRY
  • 4.3 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
    • FIGURE 18 SALMONELLA TO ACCOUNT FOR THE LARGEST SHARE FOR ENTERIC DISEASE TESTING IN 2020
  • 4.4 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
  • 4.5 ENTERIC DISEASE TESTING MARKET IN FOOD, BY REGION & SUBSEGMENT
  • 4.6 ENTERIC DISEASE TESTING MARKET: MAJOR REGIONAL SUBMARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 INCREASE IN FOODBORNE ILLNESSES
    • FIGURE 22 NUMBER OF FOODBORNE ILLNESSES ACROSS THE GLOBE, 2020 (MILLION)
    • FIGURE 23 US: TOP FIVE PATHOGENS CONTRIBUTING TO FOODBORNE ILLNESSES, 2020
  • 5.3 MARKET DYNAMICS
    • FIGURE 24 ENTERIC DISEASE TESTING MARKET DYNAMICS
    • 5.3.1 DRIVERS
      • 5.3.1.1 Increase in the number of food recalls
    • FIGURE 25 EU: NUMBER OF FOOD RECALLS, 2017-2020
    • FIGURE 26 US: REASONS FOR RECALL OF FOOD, 2020
      • 5.3.1.2 Rise in demand for convenience foods
    • FIGURE 27 READY-TO-EAT FOODS MOST AFFECTED BY FOOD RECALLS, 2020
    • FIGURE 28 RISE IN GLOBAL MEAT EXPORTS, 2017-2020 (KT)
      • 5.3.1.3 Increase in global trade owing to higher disposable income among consumers
    • FIGURE 29 GLOBAL AGRI-FOOD EXPORT VALUE, BY KEY COUNTRY, 2016-2018 (USD BILLION)
    • FIGURE 30 COUNTRY-WISE PREPARED FOODS TRADE SCENARIOS, BY KEY COUNTRY, 2019 (USD MILLION)
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Lack of proper regulations governing pathogen testing in the developing economies
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Technological innovations in the food safety testing industry
      • 5.3.3.2 R&D investment directed toward the development of PCR technology for improved pathogen testing
    • TABLE 2 R&D INVESTMENT BY MAJOR COMPANIES
    • 5.3.4 CHALLENGES
      • 5.3.4.1 High cost associated with testing of food and water

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 REGULATORY FRAMEWORK
    • 6.2.1 INTRODUCTION
    • 6.2.2 INTERNATIONAL BODIES FOR FOOD SAFETY STANDARDS AND REGULATIONS
      • 6.2.2.1 Codex Alimentarius Commission (CAC)
      • 6.2.2.2 Global Food Safety Initiative (GFSI)
    • 6.2.3 NORTH AMERICA
      • 6.2.3.1 US regulations
      • 6.2.3.2 Mexico
      • 6.2.3.3 Canada
    • 6.2.4 EUROPE
      • 6.2.4.1 Microbiological criteria regulation
      • 6.2.4.2 General food law for food safety
      • 6.2.4.3 Germany
      • 6.2.4.4 UK
      • 6.2.4.5 France
      • 6.2.4.6 Italy
      • 6.2.4.7 Poland
    • 6.2.5 ASIA PACIFIC
      • 6.2.5.1 China
    • TABLE 3 PATHOGEN LIMITS FOR FOOD
      • 6.2.5.2 India
      • 6.2.5.3 Japan
      • 6.2.5.4 Australia
      • 6.2.5.5 New Zealand
    • 6.2.6 SOUTH AMERICA
      • 6.2.6.1 Brazil
      • 6.2.6.2 Ministry of Agriculture, Livestock, and Food Supply (MAPA)
      • 6.2.6.3 Ministry of Health (MS)
      • 6.2.6.4 Argentina
  • 6.3 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 ENTERIC DISEASE TESTING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 6.3.1 THREAT OF NEW ENTRANTS
    • 6.3.2 THREAT OF SUBSTITUTES
    • 6.3.3 BARGAINING POWER OF SUPPLIERS
    • 6.3.4 BARGAINING POWER OF BUYERS
    • 6.3.5 DEGREE OF COMPETITION
  • 6.4 MARKET ECOSYSTEM
    • FIGURE 31 ENTERIC DISEASE TESTING MARKET ECOSYSTEM MAP
    • 6.4.1 UPSTREAM
    • 6.4.2 DOWNSTREAM
    • TABLE 5 COMPANY MARKET ECOSYSTEM
  • 6.5 SUPPLY CHAIN ANALYSIS
    • FIGURE 32 REGULATORY BODIES: ENTERIC DISEASE TESTING MARKET
    • 6.5.1 R&D
    • 6.5.2 PRODUCTION
    • 6.5.3 PROCESSING & TRANSFORMING
    • 6.5.4 TRANSPORTATION
    • 6.5.5 FINAL PREPARATION
    • 6.5.6 DISTRIBUTION
  • 6.6 TECHNOLOGY ANALYSIS
  • 6.7 PATENT ANALYSIS
    • FIGURE 33 PATENT ANALYSIS, 2017-2020
    • TABLE 6 KEY PATENTS FILED IN THE ENTERIC DISEASES TESTING MARKET, 2018- 2021
  • 6.8 CASE STUDIES
    • TABLE 7 AUTOMATED PATHOGEN DETECTION USING VIDAS ADVANCED TESTING SOLUTION
  • 6.9 DISRUPTIONS IMPACTING BUYERS IN THE MARKET
    • FIGURE 34 THE DEMAND FOR CONVENIENCE FOODS IS DRIVING THE MARKET FOR ENTERIC DISEASE TESTING IN FROZEN FRUITS & VEGETABLES
  • 6.10 IMPACT OF COVID-19 ON MARKET DYNAMICS
    • 6.10.1 COVID-19 INCREASED THE DEMAND FOR FOOD SAFETY AND ASSESSMENT
    • 6.10.2 COVID-19 HAS SHIFTED THE FOCUS TOWARDS GENERAL HYGIENE SERVICES FROM FOOD SAFETY

7 ENTERIC DISEASE TESTING MARKET, BY PATHOGEN

  • 7.1 INTRODUCTION
    • FIGURE 35 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021 VS. 2026 (USD MILLION)
    • TABLE 8 PATHOGENESIS OF COMMON PATHOGENS
    • FIGURE 36 US: FOODBORNE DISEASE OUTBREAKS, OUTBREAK-ASSOCIATED ILLNESSES, AND HOSPITALIZATIONS, 2019
    • TABLE 9 US: INCIDENCE OF BACTERIAL AND PARASITIC INFECTIONS, 2019
    • TABLE 10 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 11 ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021-2026 (USD MILLION)
    • 7.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY PATHOGEN
      • 7.1.1.1 Realistic Scenario
    • TABLE 12 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 13 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021-2026 (USD MILLION)
      • 7.1.1.2 Optimistic Scenario
    • TABLE 14 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 15 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021-2026 (USD MILLION)
      • 7.1.1.3 Pessimistic Scenario
    • TABLE 16 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 17 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN, 2021-2026 (USD MILLION)
    • 7.1.2 E. COLI
      • 7.1.2.1 Proper food safety testing can limit the incidences of E. coli food poisoning
    • FIGURE 37 US: ANNUAL NUMBER OF E. COLI OUTBREAKS, 2009-2018
    • FIGURE 38 TRANSMISSION CYCLE OF ETEC (ENTEROTOXIGENIC E. COLI)
    • TABLE 18 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 19 E. COLI TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 7.1.3 SALMONELLA
      • 7.1.3.1 Salmonella foodborne infection is found to be severe during summer than in winter
    • FIGURE 39 US: SALMONELLA OUTBREAKS, BY NUMBER AND CAUSE, 2009-2018
    • TABLE 20 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 21 SALMONELLA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 7.1.4 CAMPYLOBACTER
      • 7.1.4.1 WHO is strengthening disease surveillance to prevent foodborne illness
    • FIGURE 40 US: ANNUAL CAMPYLOBACTER OUTBREAKS, 2009-2018
    • TABLE 22 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 23 CAMPYLOBACTER TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 7.1.5 LISTERIA
      • 7.1.5.1 L. monocytogenes causes high hospitalization rate than any other foodborne pathogen
    • TABLE 24 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 25 LISTERIA TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 7.1.6 OTHER PATHOGENS
    • TABLE 26 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 27 OTHER PATHOGENS TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)

8 ENTERIC DISEASE TESTING MARKET, BY END USE

  • 8.1 INTRODUCTION
    • FIGURE 41 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF NON-ANIMAL ORIGIN, 2019
    • FIGURE 42 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021 VS. 2026 (USD MILLION)
    • TABLE 28 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 29 ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 30 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 31 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 8.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY END USE
      • 8.1.1.1 Realistic scenario
    • TABLE 32 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 33 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
      • 8.1.1.2 Optimistic scenario
    • TABLE 34 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 35 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
      • 8.1.1.3 Pessimistic scenario
    • TABLE 36 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 37 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
  • 8.2 FOOD
    • 8.2.1 MEAT & POULTRY PRODUCTS TO PROVIDE MORE SCOPE FOR FOOD TESTING
    • TABLE 38 ENTERIC DISEASE TESTING MARKET FOR FOOD SOURCE, BY FOODBORNE PATHOGENS
    • FIGURE 43 EU: FOODBORNE DISEASE OUTBREAKS, 2017
    • TABLE 39 EU: OCCURRENCE OF CAMPYLOBACTER IN MAJOR FOOD CATEGORIES
    • TABLE 40 US: FOOD RECALLS, 2020
    • TABLE 41 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 42 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 43 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 44 ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY PATHOGEN, 2021-2026 (USD MILLION)
    • 8.2.2 MEAT, POULTRY, AND SEAFOOD
      • 8.2.2.1 Unclean slaughterhouses and processing plants are the key contributors to bacterial contamination
    • FIGURE 44 EU: FREQUENCY DISTRIBUTION OF FOODBORNE OUTBREAKS THROUGH FOODS OF ANIMAL ORIGIN, 2019
    • TABLE 45 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 46 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 47 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 48 ENTERIC DISEASE TESTING MARKET SIZE IN MEAT, POULTRY, & SEAFOOD, BY PATHOGEN, 2021-2026 (USD MILLION)
    • 8.2.3 DAIRY PRODUCTS
      • 8.2.3.1 Unhygienic storage conditions lead to contamination of dairy products
    • FIGURE 45 EU: FREQUENCY DISTRIBUTION OF ILLNESSES IN DAIRY PRODUCTS, 2019
    • TABLE 49 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 50 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 51 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 52 ENTERIC DISEASE TESTING MARKET SIZE IN DAIRY PRODUCTS, BY PATHOGEN, 2021-2026 (USD MILLION)
    • 8.2.4 PROCESSED FOOD
      • 8.2.4.1 Ready-To-Eat foods are gaining more traction among consumers
    • TABLE 53 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOOD, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 54 ENTERIC DISEASE TESTING MARKET SIZE FOR PROCESSED FOOD, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 55 ENTERIC DISEASE TESTING MARKET IN PROCESSED FOODS, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 56 ENTERIC DISEASE TESTING MARKET SIZE IN PROCESSED FOODS, BY PATHOGEN, 2021-2026 (USD MILLION)
    • 8.2.5 FRUITS & VEGETABLES
      • 8.2.5.1 Good handling practices can help in the safe production of fresh produce
    • TABLE 57 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 58 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 59 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 60 ENTERIC DISEASE TESTING MARKET SIZE IN FRUITS & VEGETABLES, BY PATHOGEN, 2021-2026 (USD MILLION)
    • 8.2.6 OTHER FOOD APPLICATIONS
    • TABLE 61 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 62 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 63 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 64 ENTERIC DISEASE TESTING MARKET SIZE IN OTHER FOOD APPLICATIONS, BY PATHOGEN, 2021-2026 (USD MILLION)
  • 8.3 WATER
    • 8.3.1 POOR HYGIENIC CONDITIONS LEAD TO WATERBORNE DISEASES IN DEVELOPING REGIONS
    • TABLE 65 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 66 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 67 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2016-2020 (USD MILLION)
    • TABLE 68 ENTERIC DISEASE TESTING MARKET SIZE IN WATER, BY PATHOGEN, 2021-2026 (USD MILLION)

9 ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY

  • 9.1 INTRODUCTION
    • FIGURE 46 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
    • TABLE 69 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 70 ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021-2026 (USD MILLION)
    • 9.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY TECHNOLOGY
      • 9.1.1.1 Realistic scenario
    • TABLE 71 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 72 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021-2026 (USD MILLION)
      • 9.1.1.2 Optimistic scenario
    • TABLE 73 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 74 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021-2026 (USD MILLION)
      • 9.1.1.3 Pessimistic scenario
    • TABLE 75 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 76 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2021-2026 (USD MILLION)
  • 9.2 TRADITIONAL
    • 9.2.1 CULTURAL TECHNIQUES HAVE BEEN PREFERRED FOR BOTH READY-TO-EAT FOODS AND FRESH PRODUCE
    • TABLE 77 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 78 TRADITIONAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021-2026 (USD MILLION)
  • 9.3 RAPID
    • TABLE 79 ENTERIC DISEASE TESTING MARKET SIZE FOR RAPID TECHNOLOGY, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 80 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 81 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 82 RAPID ENTERIC DISEASE TESTING MARKET SIZE, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 9.3.1 CONVENIENCE-BASED
      • 9.3.1.1 Helps detect microorganisms based on their biochemical reactions under standard growth conditions
    • 9.3.2 POLYMERASE CHAIN REACTION (PCR)
      • 9.3.2.1 Real-time PCR involves fluorescent ethidium bromide monoazide dye that prevent the detection of dead organisms
    • 9.3.3 IMMUNOASSAY
      • 9.3.3.1 ELISA is based on the protein's characteristic of binding to specific enzyme-labeled antibodies
    • 9.3.4 CHROMATOGRAPHY & SPECTROMETRY
      • 9.3.4.1 Inductively Coupled Plasma (ICP) is one of the major advancements of mass spectrometry

10 ENTERIC DISEASE TESTING MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 47 REGION-WISE FOOD SAFETY EVENTS, 2020
    • FIGURE 48 US ESTIMATED TO GROW AT THE HIGHEST GROWTH RATE IN THE ENTERIC DISEASE TESTING MARKET, 2021-2026
    • TABLE 83 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 84 ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021-2026 (USD MILLION)
    • 10.1.1 COVID-19 IMPACT ON THE ENTERIC DISEASE TESTING MARKET, BY REGION
      • 10.1.1.1 Realistic scenario
    • TABLE 85 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 86 REALISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021-2026 (USD MILLION)
      • 10.1.1.2 Optimistic scenario
    • TABLE 87 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 88 OPTIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021-2026 (USD MILLION)
      • 10.1.1.3 Pessimistic scenario
    • TABLE 89 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 90 PESSIMISTIC SCENARIO: ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2021-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 49 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020
    • TABLE 91 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 92 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 93 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 94 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 95 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 96 NORTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 FSIS is the regulating body that enforces food safety regulations
    • FIGURE 50 NUMBER OF DEATHS RELATED TO CONFIRMED INFECTIONS, BY PATHOGEN, 2010-2018
    • FIGURE 51 US: FOODBORNE PATHOGEN INCIDENCE RATE PER 100,000 PERSONS, 2010-2016
    • TABLE 97 US: ESTIMATED EFFECTS OF FOODBORNE AGENTS (2016)
    • FIGURE 52 US: INCIDENCES RELATED TO THE TOP FIVE FOODBORNE PATHOGENS, 2016
    • TABLE 98 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 99 US: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 100 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 101 US: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Canadian government imposed stringent regulations on exports to ensure food safety
    • TABLE 102 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 103 CANADA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 104 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 105 CANADA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.2.3 MEXICO
      • 10.2.3.1 Rise in the number of foodborne disease cases has increased focus on food safety in the country
    • TABLE 106 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 107 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 108 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 109 MEXICO: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
  • 10.3 EUROPE
    • FIGURE 53 EU/EEA: DISTRIBUTION OF CONFIRMED CAMPYLOBACTERIOSIS CASES AND RATES PER 100 000 POPULATION BY YEAR AND COUNTRY, 2013-2017
    • FIGURE 54 EUROPE: ENTERIC DISEASE TESTING MARKET SNAPSHOT, 2020
    • TABLE 110 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 111 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 112 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 113 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 114 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 115 EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 International food trade has increased food safety risks
    • FIGURE 55 GERMANY: ACTIVE FOOD TESTING CARRIED OUT FOR VARIOUS FOOD PATHOGENS IN MULTIPLE FOOD PRODUCTS, 2019
    • TABLE 116 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 117 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 118 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 119 GERMANY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Large number of foodborne outbreaks in meat-based food encouraging the growth of enteric disease testing
    • TABLE 120 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 121 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 122 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 123 FRANCE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.3.3 SPAIN
      • 10.3.3.1 Outbreak of listeriosis will have serious implications on the Spanish meat industry
    • TABLE 124 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 125 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 126 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 127 SPAIN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Products of animal origin products are found to be more problematic in this region
    • TABLE 128 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 129 ITALY: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 130 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 131 ITALY: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.3.5 POLAND
      • 10.3.5.1 Increase in incidences of Salmonella outbreaks drives awareness about food safety
    • TABLE 132 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 133 POLAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 134 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENTS, 2016-2020 (USD MILLION)
    • TABLE 135 POLAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.3.6 UK
      • 10.3.6.1 Norovirus infection is estimated to occur every year in the UK
    • TABLE 136 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 137 UK: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 138 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 139 UK: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 140 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 141 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 142 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 143 REST OF EUROPE: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • TABLE 144 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016-2020 (USD MILLION)
    • TABLE 145 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021-2026 (USD MILLION)
    • TABLE 146 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 147 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 148 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 149 ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 E. coli to be the major pathogen found to affect people
    • TABLE 150 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 151 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 152 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 153 JAPAN: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Microbial contamination is reported to be the biggest food safety risk
    • TABLE 154 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 155 CHINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 156 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 157 CHINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 FSSAI to safeguard the quality of food produced
    • TABLE 158 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 159 INDIA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 160 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 161 INDIA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.4.4 AUSTRALIA & NEW ZEALAND
      • 10.4.4.1 Gastroenteritis occurs every year, affecting several people
    • TABLE 162 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 163 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 164 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 165 AUSTRALIA & NEW ZEALAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.4.5 THAILAND
      • 10.4.5.1 Demand for food exports to boost the growth of the market
    • TABLE 166 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 167 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 168 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 169 THAILAND: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 170 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 171 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 172 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 173 REST OF ASIA PACIFIC: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
  • 10.5 SOUTH AMERICA
    • TABLE 174 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 175 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 176 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 177 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 178 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET FOR FOOD END USE, BY SUBSEGMENT,2016-2020 (USD MILLION)
    • TABLE 179 SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Export of agricultural produce to boost the demand for enteric disease testing
    • TABLE 180 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 181 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 182 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 183 BRAZIL: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.5.2 ARGENTINA
      • 10.5.2.1 Food companies are taking preventive measures for pathogen infections
    • TABLE 184 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 185 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 186 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 187 ARGENTINA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.5.3 REST OF SOUTH AMERICA
    • TABLE 188 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 189 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 190 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 191 REST OF SOUTH AMERICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
  • 10.6 REST OF THE WORLD (ROW)
    • TABLE 192 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2016-2020 (USD MILLION)
    • TABLE 193 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY/REGION, 2021-2026 (USD MILLION)
    • TABLE 194 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 195 ROW: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 196 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 197 ROW: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.6.1 SOUTH AFRICA
      • 10.6.1.1 Growth in the demand to follow international standards is encouraging enteric disease testing
    • TABLE 198 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 199 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 200 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 201 SOUTH AFRICA: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)
    • 10.6.2 MIDDLE EAST
      • 10.6.2.1 Food safety services are driven by food imports from other countries
    • TABLE 202 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2016-2020 (USD MILLION)
    • TABLE 203 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE, BY END USE, 2021-2026 (USD MILLION)
    • TABLE 204 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2016-2020 (USD MILLION)
    • TABLE 205 MIDDLEAST: ENTERIC DISEASE TESTING MARKET SIZE IN FOOD, BY SUBSEGMENT, 2021-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN THE ENTERIC DISEASES TESTING MARKET
  • 11.3 MARKET SHARE ANALYSIS, 2020
    • FIGURE 56 MARKET SHARE OBTAINED BY DOMINANT AND OTHER PLAYERS
  • 11.4 COVID-19-SPECIFIC COMPANY RESPONSE
    • 11.4.1 SGS SA
    • 11.4.2 MERCK KGAA
    • 11.4.3 EUROFINS SCIENTIFIC
  • 11.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 57 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (KEY PLAYERS)
  • 11.6 PRODUCT FOOTPRINT
    • TABLE 206 COMPANY FOOTPRINT, BY TECHNOLOGY
    • TABLE 207 COMPANY FOOTPRINT, BY END-USE
    • TABLE 208 COMPANY FOOTPRINT, BY REGION
  • 11.7 COMPANY EVALUATION QUADRANT (START-UP/SME)
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 STARTING BLOCKS
    • 11.7.3 RESPONSIVE COMPANIES
    • 11.7.4 DYNAMIC COMPANIES
    • FIGURE 58 ENTERIC DISEASE TESTING MARKET: COMPANY EVALUATION QUADRANT, 2020 (START-UPS/SME)
  • 11.8 COMPETITIVE SCENARIO
    • 11.8.1 NEW PRODUCTS LAUNCHES
    • TABLE 209 ENTERIC DISEASE TESTING MARKET: NEW PRODUCT LAUNCHES, JULY 2019
    • 11.8.2 DEALS
    • TABLE 210 ENTERIC DISEASE TESTING MARKET: DEALS, MAY 2017- JULY 2021
    • 11.8.3 OTHER DEVELOPMENTS
    • TABLE 211 ENTERIC DISEASE TESTING MARKET: OTHER DEVELOPMENTS, MAY 2018- JUNE 2021

12 COMPANY PROFILES

  • (Business overview, Products offered, Recent developments & MnM View)**
  • 12.1 KEY COMPANIES
    • 12.1.1 SGS SA
    • TABLE 212 SGS SA: BUSINESS OVERVIEW
    • FIGURE 59 SGS SA: COMPANY SNAPSHOT
    • TABLE 213 SGS SA: PRODUCT OFFERINGS
    • TABLE 214 SGA SA: DEALS
    • TABLE 215 SGS SA: OTHERS
    • 12.1.2 MERCK KGAA
    • TABLE 216 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 60 MERCK KGAA: COMPANY SNAPSHOT
    • TABLE 217 MERCK KGAA: PRODUCT OFFERINGS
    • 12.1.3 THERMO FISHER SCIENTIFIC INC.
    • TABLE 218 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 61 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
    • TABLE 219 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
    • TABLE 220 THERMO FISHER SCIENTIFIC INC.: DEALS
    • 12.1.4 EUROFINS SCIENTIFIC
    • TABLE 221 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 62 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
    • TABLE 222 EUROFINS SCIENTIFIC: PRODUCT OFFERINGS
    • TABLE 223 EUROFINS SCIENTIFIC: DEALS
    • TABLE 224 EUROFINS SCIENTIFIC: OTHER DEVELOPMENTS
    • 12.1.5 ALS LIMITED
    • TABLE 225 ALS LIMITED: BUSINESS OVERVIEW
    • FIGURE 63 ALS LIMITED: COMPANY SNAPSHOT
    • TABLE 226 ALS LIMITED: PRODUCT OFFERINGS
    • TABLE 227 ALS LIMITED: DEALS
    • TABLE 228 ALS LIMITED: OTHER DEVELOPMENTS
    • 12.1.6 ASURE QUALITY
    • TABLE 229 ASURE QUALITY: BUSINESS OVERVIEW
    • FIGURE 64 ASURE QUALITY: COMPANY SNAPSHOT
    • TABLE 230 ASURE QUALITY: PRODUCT OFFERINGS
    • 12.1.7 BUREAU VERITAS
    • TABLE 231 BUREAU VERITAS: BUSINESS OVERVIEW
    • FIGURE 65 BUREAU VERITAS: COMPANY SNAPSHOT
    • TABLE 232 BUREAU VERITAS: PRODUCT OFFERINGS
    • 12.1.8 INTERTEK
    • TABLE 233 INTERTEK: BUSINESS OVERVIEW
    • FIGURE 66 INTERTEK: COMPANY SNAPSHOT
    • TABLE 234 INTERTEK: PRODUCT OFFERINGS
    • TABLE 235 INTERTEK: DEALS
    • 12.1.9 BIO-RAD LABORATORIES, INC.
    • TABLE 236 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 67 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
    • TABLE 237 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS
    • 12.1.10 BECTON DICKINSON
    • TABLE 238 BECTON DICKINSON: BUSINESS OVERVIEW
    • FIGURE 68 BECTON DICKINSON: COMPANY SNAPSHOT
    • TABLE 239 BECTON DICKINSON: PRODUCT OFFERINGS
    • 12.1.11 3M
    • TABLE 240 3M: BUSINESS OVERVIEW
    • FIGURE 69 3M: COMPANY SNAPSHOT
    • TABLE 241 3M: PRODUCT OFFERINGS
    • 12.1.12 PERKINELMER, INC.
    • TABLE 242 PERKINELMER, INC.: BUSINESS OVERVIEW
    • FIGURE 70 PERKINELMER, INC.: COMPANY SNAPSHOT
    • TABLE 243 PERKINELMER, INC.: PRODUCT OFFERINGS
    • 12.1.13 NEOGEN CORPORATION
    • TABLE 244 NEOGEN CORPORATION: BUSINESS OVERVIEW
    • FIGURE 71 NEOGEN CORPORATION: COMPANY SNAPSHOT
    • TABLE 245 NEOGEN CORPORATION: PRODUCT OFFERINGS
    • 12.1.14 MERIEUX NUTRISCIENCES
    • TABLE 246 MERIEUX NUTRISCIENCES: BUSINESS OVERVIEW
    • TABLE 247 MERIEUX NUTRISCIENCES: PRODUCT OFFERINGS
    • TABLE 248 MERIEUX NUTRISCIENCES: DEALS
    • 12.1.15 TUV SUD
    • TABLE 249 TUV SUD: BUSINESS OVERVIEW
    • TABLE 250 TUV SUD: PRODUCT OFFERINGS
  • *Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 HARDY DIAGNOSTICS
    • TABLE 251 HARDY DIAGNOSTICS: BUSINESS OVERVIEW
    • TABLE 252 HARDY DIAGNOSTICS: PRODUCT OFFERINGS
    • TABLE 253 HARDY DIAGNOSTICS: NEW PRODUCT LAUNCH
    • 12.2.2 ROMER LABS
    • TABLE 254 ROMER LABS: BUSINESS OVERVIEW
    • TABLE 255 ROMER LABS: PRODUCT OFFERINGS
    • 12.2.3 NOVA BIOLOGICALS
    • TABLE 256 NOVA BIOLOGICALS: BUSINESS OVERVIEW
    • TABLE 257 NOVA BIOLOGICALS: PRODUCT OFFERINGS
    • 12.2.4 SYMBIO LABORATORIES
    • TABLE 258 SYMBIO LABORATORIES: BUSINESS OVERVIEW
    • TABLE 259 SYMBIO LABORATORIES: PRODUCT OFFERINGS
    • 12.2.5 CERTIFIED LABORATORIES

13 ADJACENT AND RELATED MARKETS

  • 13.1 INTRODUCTION
    • TABLE 260 ADJACENT MARKETS TO ENTERIC DISEASE TESTING MARKET
  • 13.2 LIMITATIONS
  • 13.3 FOOD PATHOGEN TESTING MARKET
    • 13.3.1 MARKET DEFINITION
    • 13.3.2 MARKET OVERVIEW
    • TABLE 261 E. COLI MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
    • TABLE 262 SALMONELLA MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
    • TABLE 263 CAMPYLOBACTER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
    • TABLE 264 LISTERIA MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • 13.4 FOOD TESTING KITS MARKET
    • 13.4.1 MARKET DEFINITION
    • 13.4.2 MARKET OVERVIEW
    • TABLE 265 FOOD TESTING KITS MARKET SIZE IN MEAT, POULTRY, AND SEAFOOD PRODUCTS, BY REGION, 2015-2022 (USD MILLION)
    • TABLE 266 FOOD TESTING KITS MARKET SIZE IN DAIRY PRODUCTS, BY REGION, 2015-2022 (USD MILLION)
    • TABLE 267 FOOD TESTING KITS MARKET SIZE IN PROCESSED FOOD, BY REGION, 2015-2022 (USD MILLION)
    • TABLE 268 FOOD TESTING KITS MARKET SIZE IN FRUITS & VEGETABLES, BY REGION, 2015-2022 (USD MILLION)
  • 13.5 MICROBIAL WATER TESTING MARKET
    • 13.5.1 MARKET DEFINITION
    • 13.5.2 MARKET OVERVIEW
    • TABLE 269 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY WATER TYPE, 2015-2022 (USD MILLION)
    • TABLE 270 MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
    • TABLE 271 DRINKING & BOTTLED MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)
    • TABLE 272 INDUSTRIAL MICROBIAL WATER TESTING SOLUTIONS MARKET SIZE, BY TYPE, 2015-2022 (USD MILLION)

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 AVAILABLE CUSTOMIZATIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS